KAUST researchers led by Dr. Niveen Khashab have developed thermosensitive liposomes for controlled drug release, particularly in cancer therapies. The liposomes are designed to release drugs only when they reach heated tumor tissue, minimizing systemic side effects. Cholesterol moieties are used as anchors to create a "nail" or "comb" effect, enabling temperature-triggered drug release inside cells. Why it matters: This targeted drug delivery system could significantly improve the efficacy and reduce the toxicity of cancer treatments.
Petar Stojanov from the Broad Institute of MIT and Harvard will give a talk on cancer data analysis, covering the fundamentals of cancer, the nature of large-scale data collected, and main analysis objectives. The talk will also address open questions in cancer data analysis and how machine learning and generative modeling can help. Stojanov's research focuses on applying machine learning to genomic analysis of cancer mutation and single-cell RNA sequencing data. Why it matters: Applying AI and machine learning to cancer research can lead to a better understanding of the disease and development of new therapies.
KAUST researchers developed a statistical approach to improve the identification of cancer-related protein mutations by reducing false positives. The method uses Bayesian statistics to analyze protein domain data from tumor samples, accounting for potential errors due to limited data. The team tested their method on prostate cancer data, successfully identifying a known cancer-linked mutation in the DNA binding protein cd00083. Why it matters: This enhances the reliability of cancer research at the molecular level, potentially accelerating the discovery of new therapeutic targets.
This article discusses the use of artificial intelligence in precision oncology, particularly in understanding individual tumor mechanisms and aiding clinical decision-making. Dr. Xinghua Lu, with extensive experience in medicine and biomedical informatics, will present research on individualized Bayesian causal inference methods for investigating oncogenic mechanisms. These methods aim to provide clinical decision support at the cellular, tumor, and patient levels. Why it matters: AI-driven precision oncology can enable more personalized and effective cancer treatments, improving patient outcomes in the region and globally.
KAUST researchers demonstrated a new flash memory device design using gallium oxide, which can withstand harsh environments. In collaboration with the University of Michigan, KAUST researchers explained a key molecular event for the activation of an enzyme associated with cancer. The Summer 2023 issue of KAUST Discovery is now available. Why it matters: These research achievements highlight KAUST's contributions to advanced materials science and biomedical research, with potential applications in space technology and cancer treatment.
KAUST researchers have made several advances, including a new computational model of the Red Sea's ocean circulation. They also synthesized new metal-organic frameworks for gas storage with applications in green and medical tech. Additionally, they presented a mathematical solution for microgrid cybersecurity. Why it matters: These diverse research projects highlight KAUST's contributions to environmental modeling, materials science, and critical infrastructure protection in the region.
Professor Arnab Pain's group at KAUST discovered new insights on how a malaria protein enables parasites to spread malaria in human cells. Professor Haavard Rue's group upgraded the Integrated and Nested Laplace Approximation (INLA) for faster real-time modeling of large datasets. A KAUST-led study examined the stability of Y-series nonfullerene acceptors for organic solar cells. Why it matters: KAUST continues producing impactful research across diverse fields from medicine to climate change, advancing scientific knowledge and potential applications.
MBZUAI master's student Sayed Hashim is applying machine learning to improve cancer diagnosis and treatment, motivated by personal loss. He and fellow student Muhammad Ali developed algorithms for cancer type classification from multi-omics data, achieving over 96% accuracy. Their work, supervised by MBZUAI faculty, resulted in a published paper on multi-omics data representation learning. Why it matters: This research demonstrates the potential of AI and machine learning to advance cancer research and personalized medicine in the region.